Multichannel Engagement Insights
Derived from our long-running physician and patient survey-based studies, our Omnichannel Research reports identify where, when, and how to reach your target physicians and patients
Cybercitizen Health U.S. 2019 | Cancer (Dx past 3 years) Patients | With Comparison
Cybercitizen Health® US is a study and strategic advisory service focused on helping clients understand digital behavior and needs across the patient experience, meet them with the right content…
Cybercitizen Health U.S. 2019 | Rheumatoid Arthritis Patients | With Comparison
Cybercitizen Health® US is a study and strategic advisory service focused on helping clients understand digital behavior and needs across the patient experience, meet them with the right content…
Europeans are increasingly asking their doctor about Rx drugs, but pharma isn’t part of the conversation | Cybercitizen Health Europe 2019 | Strategic Insight
Questions answered in this report: What is the prevalence of EU adults requesting specific prescriptions, how has this changed from last year? What is pharma’s impact online to drive…
How can pharmas increase patient engagement with emails? | Cybercitizen Health U.S. 2019 | Strategic Insight
Cybercitizen Health® US is a study focused on helping clients understand digital behavior and needs across the patient experience, and plan for patient-centric solutions to drive outcomes. The…
Cybercitizen Health U.S. 2019 | Amyotrophic Lateral Sclerosis | Without Comparison
Cybercitizen Health® US is a study focused on helping clients understand digital behavior and needs across the patient experience, and plan for patient-centric solutions to drive outcomes. The…
Cybercitizen Health U.S. 2019 | Progressive Supranuclear Palsy | Without Comparison
Cybercitizen Health® US is a study focused on helping clients understand digital behavior and needs across the patient experience, and plan for patient-centric solutions to drive outcomes. The…
